BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for FERRING PHARMACEUTICALS INC. · biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · $50,000.00 income · posted Jul 17, 2025

Lobbying activity 2

Health Issues

issues related to microbiome, oncology, & fertility Issues related to formulary tier status Drug pricing policy

Veterans

Issues related to veteran's care and veteran's reproductive care

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.